Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-358-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110119.20.3-358-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Alzheimer’s disease and other forms of dementia are diseases that have been arousing justified attention and concern. According to the 2010 report of Alzheimer’s Disease International, approximately 9.9 million people in Europe are affected and it is predicted that this number will rise considerably by 2020. The lack of professional carers for people with Alzheimer’s has to be a cause for considerable concern, since this situation will tend to get worse in the future if measures are not taken. These measures must include the training of a sufficient number of health and social services professionals and the guarantee of appropriate care provision through public services, respecting the wish of patients to remain in their own home environment wherever possible and promoting the fundamental principles of dignity and social inclusion and also the independence and self-determination of the patients. Since this is a disease where the medication costs are very high and cannot be met by the majority of patients, increased funding for these drugs is desirable. It is absolutely essential to encourage and develop research in this area, particularly in connection with prevention, diagnosis and treatment, when the fundamental principle is that the public sector takes on these responsibilities without restrictions of benefit or access for any patient."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples